[HTML][HTML] Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe
V Tonini, M Zanni - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
While great strides in improving survival rates have been made for most cancers in recent
years, pancreatic ductal adenocarcinoma (PDAC) remains one of the solid tumors with the …
years, pancreatic ductal adenocarcinoma (PDAC) remains one of the solid tumors with the …
Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus
J Bures, D Kohoutova, J Skrha, B Bunganic, O Ngo… - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma remains one of the most serious
malignancies and a leading cause of cancer-related deaths worldwide. There are no …
malignancies and a leading cause of cancer-related deaths worldwide. There are no …
The effect of type 2 diabetes mellitus on the short-term outcomes and prognosis of stage I–III colorectal cancer: a propensity score matching analysis
Y Cheng, YX Cheng, XY Liu, B Kang… - Cancer Management …, 2023 - Taylor & Francis
Purpose The purpose of the current study was to analyze the effect of type 2 diabetes
mellitus (T2DM) on the short-term outcomes and prognosis of stage I–III colorectal cancer …
mellitus (T2DM) on the short-term outcomes and prognosis of stage I–III colorectal cancer …
The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy
C Qin, T Li, C Lin, B Zhao, Z Li, Y Zhao… - Cancer Cell …, 2024 - Springer
Pancreatic cancer remains one of the most lethal diseases worldwide. Cancer-derived
exosomes, benefiting from the protective role of the lipid membrane, exhibit remarkable …
exosomes, benefiting from the protective role of the lipid membrane, exhibit remarkable …
Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects
N Casarcia, P Rogers, E Guld, S Iyer… - British Journal of …, 2023 - Wiley Online Library
Pancreatic cancer is the third leading cause of cancer‐related deaths in the United States,
owing to its aggressive nature and suboptimal treatment options, emphasizing the need for …
owing to its aggressive nature and suboptimal treatment options, emphasizing the need for …
Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer
L Magni, H Yu, NM Christensen, MH Poulsen… - Cancer Cell …, 2024 - Springer
Abstract Background The purinergic P2X7 receptor (P2X7R) plays an important role in the
crosstalk between pancreatic stellate cells (PSCs) and cancer cells, thus promoting …
crosstalk between pancreatic stellate cells (PSCs) and cancer cells, thus promoting …
Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer
M Caban, E Małecka-Wojciesko - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic cancer, including primarily pancreatic ductal adenocarcinoma
(PDAC), represents a highly lethal disease and an increasingly common cause of cancer …
(PDAC), represents a highly lethal disease and an increasingly common cause of cancer …
Role of pancreatic tumour-derived exosomes and their cargo in pancreatic cancer-related diabetes
HB Binang, CJ Perera, MV Apte - International Journal of Molecular …, 2023 - mdpi.com
One of the most common and deadly types of pancreatic cancer (PC) is pancreatic ductal
adenocarcinoma (PDAC), with most patients succumbing to the disease within one year of …
adenocarcinoma (PDAC), with most patients succumbing to the disease within one year of …
Determining the summer indoor design parameters for pensioners' buildings based on the thermal requirements of elderly people at different ages
G Zheng, C Wei, K Li - Energy, 2022 - Elsevier
Due to the declining of physiological functions, the thermal requirements of elderly people at
different ages are different. This paper aims to propose different indoor design parameters …
different ages are different. This paper aims to propose different indoor design parameters …
[HTML][HTML] Incretin based therapy and pancreatic cancer: Realising the reality
Incretin-based therapies like glucagon-like peptide-1 receptor agonists and dipeptidyl
peptidase-4 inhibitors help maintain the glycaemic control in patients with type 2 diabetes …
peptidase-4 inhibitors help maintain the glycaemic control in patients with type 2 diabetes …